Clinical Trial Update: γδ T-PD-1 Ab Cells in the Treatment of Malignant Meningioma [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating γδ T-PD-1 Ab Cells for malignant meningioma; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Meningioma

Drugs mentioned

• γδ T-PD-1 Ab Cells

Snippet

Sponsor: Nanjing Medical University | Conditions: Malignant Meningioma | EARLY_Phase 1 | Status: NOT_YET_RECRUITING